Fresenius Medical Care (NYSE:FMS) Upgraded at StockNews.com

Fresenius Medical Care (NYSE:FMS - Get Free Report) was upgraded by equities researchers at StockNews.com from a "hold" rating to a "strong-buy" rating in a report issued on Wednesday.

Several other brokerages also recently issued reports on FMS. Berenberg Bank initiated coverage on Fresenius Medical Care in a report on Wednesday, November 6th. They issued a "buy" rating and a $25.60 price target for the company. Truist Financial increased their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a "hold" rating in a research note on Monday, January 6th. Finally, Bank of America raised shares of Fresenius Medical Care from an "underperform" rating to a "neutral" rating in a research note on Monday, December 2nd.

Fresenius Medical Care Trading Up 0.2 %

Shares of FMS traded up $0.05 during trading hours on Wednesday, reaching $24.35. The stock had a trading volume of 218,195 shares, compared to its average volume of 230,833. The company has a market cap of $14.29 billion, a P/E ratio of 20.12, a P/E/G ratio of 0.80 and a beta of 0.93. Fresenius Medical Care has a 52 week low of $17.93 and a 52 week high of $25.25. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The firm has a 50-day moving average of $23.41 and a 200 day moving average of $21.39.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Smartleaf Asset Management LLC boosted its holdings in Fresenius Medical Care by 192.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after purchasing an additional 806 shares during the last quarter. Allworth Financial LP boosted its stake in shares of Fresenius Medical Care by 53.1% during the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company's stock worth $36,000 after buying an additional 581 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Fresenius Medical Care in the 3rd quarter valued at about $38,000. Jones Financial Companies Lllp increased its position in shares of Fresenius Medical Care by 80.5% in the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company's stock valued at $102,000 after acquiring an additional 2,012 shares during the last quarter. Finally, GAMMA Investing LLC raised its holdings in Fresenius Medical Care by 50.4% during the third quarter. GAMMA Investing LLC now owns 4,998 shares of the company's stock worth $106,000 after acquiring an additional 1,675 shares in the last quarter. 8.37% of the stock is owned by institutional investors and hedge funds.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.